(IEDI) iShares Evolved U.S. - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46431W6637
IEDI: Consumer, Retail, Automotive, Leisure, Electronics, Apparel, Home Improvement
The iShares Evolved U.S. Discretionary Spending ETF (IEDI) is an exchange-traded fund that focuses on investing in U.S.-listed common stocks of companies across various market capitalizations within the consumer discretionary sector. The funds strategy involves concentrating on companies that are part of the Consumer Discretionary Spending Evolved Sector, with a particular emphasis on those that score higher on U.S. Consumer Scores relative to their sector peers. This approach is designed to capitalize on consumer spending trends, potentially benefiting from the growth of companies that are favored by consumers.
Given its non-diversified nature, IEDI may exhibit a higher volatility profile compared to more diversified funds, as its performance is more closely tied to the fortunes of a relatively narrower segment of the market. Investors should be aware that this fund is likely to be more sensitive to sector-specific trends and consumer behavior. The Consumer Discretionary sector is known for being cyclical, meaning its performance can be closely linked to the overall state of the economy.
Analyzing the available
From a fundamental perspective, the Assets Under Management (AUM) of $35.61M USD indicate a relatively small but still viable fund size. The size could potentially impact liquidity and the funds ability to maneuver in the market. However, being listed on BATS (now known as Cboe BZX) provides a level of credibility and accessibility to investors.
Forecasting the performance of IEDI involves considering both its technical and fundamental aspects. Given the current uptrend and the funds focus on companies with higher U.S. Consumer Scores, if consumer spending remains robust, IEDI could potentially continue its upward trajectory. A break above the 52-week high of $57.28 could signal further growth potential, while a drop below the SMA50 ($51.02) might indicate a reversal in the trend. Investors should closely monitor consumer spending trends, overall economic health, and the competitive landscape within the consumer discretionary sector to gauge the funds future performance.
Additional Sources for IEDI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IEDI ETF Overview
Market Cap in USD | 32m |
Category | Consumer Cyclical |
TER | 0.18% |
IPO / Inception | 2018-03-21 |
IEDI ETF Ratings
Growth Rating | 62.2 |
Fundamental | - |
Dividend Rating | 48.9 |
Rel. Strength | 0.37 |
Analysts | - |
Fair Price Momentum | 52.04 USD |
Fair Price DCF | - |
IEDI Dividends
Dividend Yield 12m | 0.67% |
Yield on Cost 5y | 1.22% |
Annual Growth 5y | 7.41% |
Payout Consistency | 87.4% |
Payout Ratio | % |
IEDI Growth Ratios
Growth Correlation 3m | 80.8% |
Growth Correlation 12m | 50.6% |
Growth Correlation 5y | 66.3% |
CAGR 5y | 13.34% |
CAGR/Max DD 5y | 0.45 |
Sharpe Ratio 12m | 0.41 |
Alpha | 1.30 |
Beta | 0.774 |
Volatility | 15.36% |
Current Volume | 4.6k |
Average Volume 20d | 3.9k |
As of June 30, 2025, the stock is trading at USD 54.58 with a total of 4,595 shares traded.
Over the past week, the price has changed by +1.59%, over one month by +2.65%, over three months by +7.15% and over the past year by +14.59%.
Yes. Based on ValueRay´s Analyses, iShares Evolved U.S. (BATS:IEDI) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.23 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IEDI is around 52.04 USD . This means that IEDI is currently overvalued and has a potential downside of -4.65%.
iShares Evolved U.S. has no consensus analysts rating.
According to our own proprietary Forecast Model, IEDI iShares Evolved U.S. will be worth about 59.6 in June 2026. The stock is currently trading at 54.58. This means that the stock has a potential upside of +9.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 59.6 | 9.2% |